Bruno Farah

Showing 1-8 of 8 articles

Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D

April 20, 2018 | 10.4244/EIJ-D-17-00529

Interventions for valvular disease

Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report

Molina-Martin de Nicolas J, Tchétché D, Farah B

February 12, 2016 | 10.4244/EIJV11I11A255

Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system

Tchétché D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J

September 28, 2012 | 10.4244/EIJV8I5A86

Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome

Luz A, Hughes C, Magalhaes R, Bisceglia T, Descoutures F, Tamamm K, Tchétché D, Sauguet A, Farah B, Fajadet J

January 20, 2012 | 10.4244/EIJV7I9A170

Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era

Tousek P, Pavei A, Oreglia J, Martin G, Sharif F, Fajadet J, Farah B

March 20, 2009

The use of self-expanding stents in coronary bifurcations and beyond: a paradigm revisited

Jilaihawi H, Farah B, Laborde J-C

March 20, 2009

Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome

Pavei A, Oreglia J, Martin G, Tousek P, Sharif F, Farah B, Sauguet A, Fajadet J

January 20, 2009

Percutaneous implantation of the corevalve aortic valve prosthesis for patients presenting high risk for surgical valve replacement

Laborde J-C, Borenstein N, Behr L, Farah B, Fajadet J

February 20, 2006

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease